{"id":"https://openalex.org/W1904277337","doi":"https://doi.org/10.3389/fneur.2015.00207","title":"Anti-A\u03b2 Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer\u2019s Disease and Cerebral Amyloid Angiopathy","display_name":"Anti-A\u03b2 Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer\u2019s Disease and Cerebral Amyloid Angiopathy","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-25","ids":{"openalex":"https://openalex.org/W1904277337","doi":"https://doi.org/10.3389/fneur.2015.00207","mag":"1904277337","pmid":"https://pubmed.ncbi.nlm.nih.gov/26441825","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4585101"},"language":"en","primary_location":{"id":"doi:10.3389/fneur.2015.00207","doi":"https://doi.org/10.3389/fneur.2015.00207","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2015.00207","pdf_url":"https://www.frontiersin.org/articles/10.3389/fneur.2015.00207/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1904277337"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fneur.2015.00207/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027362336","display_name":"Jacopo Cosimo DiFrancesco","orcid":"https://orcid.org/0000-0002-4102-1188","observed_orcids":["https://orcid.org/0000-0002-4102-1188"]},"institutions":[{"id":"https://openalex.org/I66752286","display_name":"University of Milano-Bicocca","ror":"https://ror.org/01ynf4891","country_code":"IT","type":"education","lineage":["https://openalex.org/I66752286"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacopo C. DiFrancesco","raw_affiliation_strings":["School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca , Monza , Italy ; The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network , Monza , Italy","School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca, Monza, Italy","The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network, Monza, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca , Monza , Italy ; The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network , Monza , Italy","institution_ids":["https://openalex.org/I66752286"]},{"raw_affiliation_string":"School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca, Monza, Italy","institution_ids":["https://openalex.org/I66752286"]},{"raw_affiliation_string":"The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network, Monza, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056632834","display_name":"Martina Longoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I66752286","display_name":"University of Milano-Bicocca","ror":"https://ror.org/01ynf4891","country_code":"IT","type":"education","lineage":["https://openalex.org/I66752286"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martina Longoni","raw_affiliation_strings":["School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca , Monza , Italy ; The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network , Monza , Italy","School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca, Monza, Italy","The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network, Monza, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca , Monza , Italy ; The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network , Monza , Italy","institution_ids":["https://openalex.org/I66752286"]},{"raw_affiliation_string":"School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca, Monza, Italy","institution_ids":["https://openalex.org/I66752286"]},{"raw_affiliation_string":"The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network, Monza, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018730040","display_name":"Fabrizio Piazza","orcid":"https://orcid.org/0000-0002-3385-3224","observed_orcids":["https://orcid.org/0000-0002-3385-3224"]},"institutions":[{"id":"https://openalex.org/I66752286","display_name":"University of Milano-Bicocca","ror":"https://ror.org/01ynf4891","country_code":"IT","type":"education","lineage":["https://openalex.org/I66752286"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Fabrizio Piazza","raw_affiliation_strings":["School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca , Monza , Italy ; The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network , Monza , Italy ; The iCA\u03b2-ITALY Study Group of the Italian Society for the Study of Dementia (SINdem) , Monza , Italy","School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca, Monza, Italy","The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network, Monza, Italy","The iCA\u03b2-ITALY Study Group of the Italian Society for the Study of Dementia (SINdem), Monza, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca , Monza , Italy ; The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network , Monza , Italy ; The iCA\u03b2-ITALY Study Group of the Italian Society for the Study of Dementia (SINdem) , Monza , Italy","institution_ids":["https://openalex.org/I66752286"]},{"raw_affiliation_string":"School of Medicine, Milan Center for Neuroscience (NeuroMi), University of Milano-Bicocca, Monza, Italy","institution_ids":["https://openalex.org/I66752286"]},{"raw_affiliation_string":"The Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease \u03b2iomarkers (iCA\u03b2) International Network, Monza, Italy","institution_ids":[]},{"raw_affiliation_string":"The iCA\u03b2-ITALY Study Group of the Italian Society for the Study of Dementia (SINdem), Monza, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5018730040"],"corresponding_institution_ids":["https://openalex.org/I66752286"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.838,"has_fulltext":true,"cited_by_count":91,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.62293853,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"6","issue":null,"first_page":"207","last_page":"207"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyloid-related-imaging-abnormalities","display_name":"amyloid-related imaging abnormalities","score":0.9789999723434448},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8069999814033508},{"id":"https://openalex.org/keywords/cerebral-amyloid-angiopathy","display_name":"cerebral amyloid angiopathy","score":0.996999979019165},{"id":"https://openalex.org/keywords/amyloid-beta-immunotherapy","display_name":"amyloid-beta immunotherapy","score":0.9300000071525574},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-biomarkers","display_name":"cerebrospinal fluid biomarkers","score":0.9769999980926514},{"id":"https://openalex.org/keywords/immunotherapy-safety","display_name":"immunotherapy safety","score":0.5519999861717224},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.5979999899864197},{"id":"https://openalex.org/keywords/clinical-trial-monitoring","display_name":"clinical trial monitoring","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C2777790613","wikidata":"https://www.wikidata.org/wiki/Q191562","display_name":"Cerebral amyloid angiopathy","level":4,"score":0.8335072994232178},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7633135318756104},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.7403554916381836},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.733796238899231},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.7323766946792603},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5065850019454956},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5012362003326416},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.49909138679504395},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39954620599746704},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3606787919998169},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.20811668038368225},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1998538374900818},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.10732227563858032},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06434682011604309},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fneur.2015.00207","doi":"https://doi.org/10.3389/fneur.2015.00207","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2015.00207","pdf_url":"https://www.frontiersin.org/articles/10.3389/fneur.2015.00207/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3571485","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4585101","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4585101","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4585101/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Neurol","raw_type":"Text"},{"id":"pmid:26441825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26441825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in neurology","raw_type":"Journal Article"},{"id":"pmh:oai:boa.unimib.it:10281/89991","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10281/89991","pdf_url":null,"source":{"id":"https://openalex.org/S4306401259","display_name":"BOA (University of Milano-Bicocca)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:f5034353d9f741f8a2417fefc8060d0a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f5034353d9f741f8a2417fefc8060d0a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Neurology, Vol 6 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fneur.2015.00207","doi":"https://doi.org/10.3389/fneur.2015.00207","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2015.00207","pdf_url":"https://www.frontiersin.org/articles/10.3389/fneur.2015.00207/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G571585116","display_name":null,"funder_award_id":"FAR -2015","funder_id":"https://openalex.org/F4320321610","funder_display_name":"Universit\u00e0 degli Studi di Milano-Bicocca"}],"funders":[{"id":"https://openalex.org/F4320314158","display_name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","ror":null},{"id":"https://openalex.org/F4320321610","display_name":"Universit\u00e0 degli Studi di Milano-Bicocca","ror":"https://ror.org/01ynf4891"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1904277337.pdf","grobid_xml":"https://content.openalex.org/works/W1904277337.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1495103533","https://openalex.org/W1580355318","https://openalex.org/W1762850625","https://openalex.org/W1824074994","https://openalex.org/W1847367856","https://openalex.org/W1892703140","https://openalex.org/W1905168637","https://openalex.org/W1907143073","https://openalex.org/W1964643578","https://openalex.org/W1970861694","https://openalex.org/W1991993391","https://openalex.org/W1993394523","https://openalex.org/W1994924162","https://openalex.org/W1995536173","https://openalex.org/W2004535959","https://openalex.org/W2008304089","https://openalex.org/W2015484447","https://openalex.org/W2021018568","https://openalex.org/W2028072761","https://openalex.org/W2030184209","https://openalex.org/W2035371573","https://openalex.org/W2042282383","https://openalex.org/W2056936299","https://openalex.org/W2058727108","https://openalex.org/W2063696444","https://openalex.org/W2063808031","https://openalex.org/W2072173867","https://openalex.org/W2082544334","https://openalex.org/W2084993078","https://openalex.org/W2086572083","https://openalex.org/W2103261758","https://openalex.org/W2108216694","https://openalex.org/W2113023788","https://openalex.org/W2118753807","https://openalex.org/W2119279113","https://openalex.org/W2122843800","https://openalex.org/W2132811144","https://openalex.org/W2144513023","https://openalex.org/W2146653387","https://openalex.org/W2158854213","https://openalex.org/W2163480552","https://openalex.org/W2164300497","https://openalex.org/W2166411759","https://openalex.org/W2168493908","https://openalex.org/W2219189983","https://openalex.org/W2280530451","https://openalex.org/W2337565256","https://openalex.org/W2517861951","https://openalex.org/W2740298679"],"related_works":["https://openalex.org/W2488688078","https://openalex.org/W2247479392","https://openalex.org/W2529988076","https://openalex.org/W3167521409","https://openalex.org/W2466570797","https://openalex.org/W7079910200","https://openalex.org/W2315542297","https://openalex.org/W7161764484","https://openalex.org/W4406268247","https://openalex.org/W4406051367"],"abstract_inverted_index":{"Amyloid-related":[0],"imaging":[1],"abnormalities":[2],"(ARIA)":[3],"represent":[4,22],"the":[5,64,67,79,87,93],"major":[6],"severe":[7],"side":[8],"effect":[9],"of":[10,20,32,66,81,90,95],"amyloid-beta":[11],"(A\u03b2)":[12],"immunotherapy":[13],"for":[14,46,104],"Alzheimer's":[15],"disease":[16],"(AD).":[17],"Early":[18],"biomarkers":[19],"ARIA":[21,105],"an":[23],"important":[24],"challenge":[25],"to":[26],"ensure":[27],"safe":[28],"and":[29,42],"beneficial":[30],"effects":[31],"immunotherapies,":[33],"given":[34],"that":[35,53],"different":[36],"promising":[37,101],"clinical":[38,107],"trials":[39],"in":[40,63,78,106],"prodromal":[41],"subjects":[43],"at":[44],"risk":[45],"AD":[47],"are":[48],"underway.":[49],"The":[50],"recent":[51],"demonstration":[52],"cerebrospinal":[54],"fluid":[55],"(CSF)":[56],"anti-A\u03b2":[57,97],"autoantibodies":[58],"play":[59],"a":[60,100],"key":[61],"role":[62],"development":[65],"ARIA-like":[68],"events":[69],"characterizing":[70],"cerebral":[71],"amyloid":[72],"angiopathy-related":[73],"inflammation":[74],"generated":[75],"great":[76],"interest":[77],"field":[80],"immunotherapy.":[82],"Herein,":[83],"we":[84],"critically":[85],"review":[86],"growing":[88],"body":[89],"evidence":[91],"supporting":[92],"monitoring":[94],"CSF":[96],"autoantibody":[98],"as":[99],"candidate":[102],"biomarker":[103],"trials.":[108]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1904277337","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
